MAGEA3 and melanoma: In addition, levels of CTAs expression, induced in melanoma cells, was stronger after treatment with guadecitabine or DAC vs. AZA, being the mean values of CTAs molecules ± SD 1.27E-02 ± 3.4E-02 and 1.09E-02 ± 2.73E-02 vs. 2.74E-03 ± 3.83E-03 for NY-ESO-1/β-actin (Figure 2A); 6.34E-04 ± 2.91E-04 and 6.45E-04 ± 3.47E-04 vs. 1.29E-04 ± 7.92E-06 for MAGE-A3/β-actin (Figure 2B); 1.29E-03 ± 1.33E-03 and 1.13E-03 ± 1.04E-03 vs. 3.19E-04 ± 2.88E-04 for MAGE-A1/β-actin (Figure 2C), respectively.